Fulcrum Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.86-$13.70
Market Cap
$200.3M
Shares Short
5M

Financials

See more
Revenue (12 Mos)
$81.6M
Revenue Growth (YoY)
8,990.9%
Gross Profit (12 Mos)
-$70.4M
Diluted EPS
-$0.34

News

See more

Yahoo Finance • 12 months ago

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • 12 months ago

Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences

Yahoo Finance • 12 months ago

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023

Yahoo Finance • last year

Fulcrum Therapeutics to Host Third Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023, at 8:00 a.m. ET

About

CEO
Mr. Alexander C. Sapir
Address
26 Landsdowne Street, Cambridge, MA, United States, 02139
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
76